简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2023-03-03 09:42 Aptorum Group Launches NativusWell®, a Novel Nutraceutical for Menopause, in China
2023-03-02 19:24 Aleph Farms Increases Production Capabilities with VBL Therapeutics Facility Acquisition and ESCO Aster Partnership
2023-03-01 16:47 Joe Kiani Provides Keynote at the 5th Annual Global Ministerial Summit on Patient Safety
2023-03-01 15:33 Microba Launches Next Generation Healthcare Testing
2023-03-01 15:22 GE HealthCare Announces Completion of Phase I Subject Recruitment in Early Clinical Development Program for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent
2023-02-28 10:20 Biocytogen’s Subsidiary Eucure Biopharma and Chipscreen Biosciences’ Holding Subsidiary Chipscreen NewWay Biosciences Enter into Greater China License Agreement for Bispecific Antibody YH008
2023-02-24 11:02 Accutar Biotechnology Announces First Patient Dosed in China with AC0176 in Phase 1 Study in Prostate Cancer
2023-02-24 09:49 Merck Highlights New Four-Year Efficacy and Safety Data for Investigational BTK Inhibitor, Evobrutinib, in RMS
2023-02-23 14:57 Ferrer Acquires Worldwide Rights to ASN90, an O-GlcNAcase Inhibitor From Asceneuron, Exclusively to Treat Progressive Supranuclear Palsy (PSP)
2023-02-23 14:44 Sinovac Amends Shareholder Rights Plan
2023-02-23 11:44 Exscientia to Present at Upcoming Investor Conferences in March
2023-02-23 09:39 LevitasBio Launches LeviSelect Suite of Cell Depletion & Enrichment Kits
2023-02-22 15:41 New Study Evaluates the Utility of Masimo ORi™ in Reducing Hyperoxemia During Laparoscopic Gastrectomy
2023-02-21 13:48 Divi’s Laboratories Selects Juniper Networks for Automated Network Infrastructure Across Massive Pharma Manufacturing Facilities
2023-02-21 10:57 Biocytogen Launches “Nano 100 Project” to Develop Fully Human Nanobody Therapeutics for Over 100 Targets
2023-02-20 09:17 Takeda Presents Positive Results from Phase 3 Study of Vedolizumab for Prevention of Intestinal Acute Graft-Versus-Host Disease (aGvHD) in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
2023-02-14 09:07 New Analyses Reinforce Survival Benefit of BAVENCIO First-Line Maintenance Treatment in Patients With Advanced Urothelial Carcinoma
2023-02-10 18:03 Global Partners Announce Innovations for Marine Managers to Help Our Oceans With Private Sector Support From Mary Kay Inc.
2023-02-10 15:32 Takeda Completes Acquisition of Nimbus Therapeutics’ TYK2 Program Subsidiary
2023-02-10 14:16 Novaliq Plans to File a Markting Authorisation Application for CyclASol® in the E.U. for the Treatment of Dry Eye Disease in July 2023

Business Wire Weibo

Press Releases

Latest Releases